Cargando…

Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects

Interstitial lung disease (ILD), as an adverse effect of certain drugs, leads to inflammation and damage in the walls of the alveoli, making it difficult for the alveoli to take up oxygen. Interstitial pneumonia with no identifiable cause is called idiopathic interstitial pneumonia (IIP), and, among...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nawa, Hideki, Hamano, Hirofumi, Niimura, Takahiro, Miyata, Koji, Yagi, Kenta, Goda, Mitsuhiro, Zamami, Yoshito, Ishizawa, Keisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747116/ https://www.ncbi.nlm.nih.gov/pubmed/36128688 http://dx.doi.org/10.1111/cts.13419

Ejemplares similares

Evaluation of Potential Complications of Interstitial Lung Disease Associated With Antiandrogens Using Data From Databases Reporting Spontaneous Adverse Effects
por: Nawa, Hideki, et al.
Publicado: (2021)

Evaluation of potential complication of interstitial lung disease with abemaciclib and palbociclib treatments
por: Nawa, Hideki, et al.
Publicado: (2021)

Drug-Repositioning Approaches Based on Medical and Life Science Databases
por: Zamami, Yoshito, et al.
Publicado: (2021)

Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database
por: Okada, Naoto, et al.
Publicado: (2018)

Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage
por: Yoshioka, Toshihiko, et al.
Publicado: (2023)

Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis( )
por: Chuma, Masayuki, et al.
Publicado: (2022)

Discovery of preventive drugs for cisplatin‐induced acute kidney injury using big data analysis
por: Kanda, Masaya, et al.
Publicado: (2022)

Effects of 5‐HT(₃) receptor antagonists on cisplatin‐induced kidney injury
por: Goda, Mitsuhiro, et al.
Publicado: (2021)

Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study
por: Okada, Naoto, et al.
Publicado: (2020)

Investigation of drugs affecting hypertension in bevacizumab‐treated patients and examination of the impact on the therapeutic effect
por: Yagi, Kenta, et al.
Publicado: (2020)

Comparison of Hemorrhagic Risk between Prasugrel and Clopidogrel: a Retrospective Study using Adverse Drug Event Reporting Databases
por: Hagiwara, Hiromi, et al.
Publicado: (2020)

Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study
por: Sakurada, Takumi, et al.
Publicado: (2022)

Preventive Effects of Quercetin against the Onset of Atherosclerosis-Related Acute Aortic Syndromes in Mice
por: Kondo, Masateru, et al.
Publicado: (2020)

Search for Therapeutic Agents for Cardiac Arrest Using a Drug Discovery Tool and Large-Scale Medical Information Database
por: Zamami, Yoshito, et al.
Publicado: (2019)

Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis
por: Horinouchi, Yuya, et al.
Publicado: (2018)

A web-based survey of educational opportunities of medical professionals based on changes in conference design during the COVID-19 pandemic
por: Yagi, Kenta, et al.
Publicado: (2022)

Trends in Head and Neck Cancer Mortality from 1999 to 2019 in Japan: An Observational Analysis
por: Higashionna, Tsukasa, et al.
Publicado: (2023)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
por: Niitsu, Takayuki, et al.
Publicado: (2023)

Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia
por: Sato, Shiho, et al.
Publicado: (2017)

A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
por: Imakura, Takeshi, et al.
Publicado: (2023)

Antifibrotic in interstitial lung diseases: When, where, and how long?
por: Rai, Deependra K., et al.
Publicado: (2022)

Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System
por: Okada, Naoto, et al.
Publicado: (2023)

Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice
por: Ikeda, Yasumasa, et al.
Publicado: (2017)

Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
por: Sugino, Keishi, et al.
Publicado: (2021)

The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease
por: Liang, Minrui, et al.
Publicado: (2022)

Use of antifibrotic drugs in familial interstitial pneumonia: analysis of one family
por: Estrella, Deborah dos Reis, et al.
Publicado: (2021)

The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease
por: Boleto, Gonçalo, et al.
Publicado: (2022)

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease
por: Wilfong, Erin M., et al.
Publicado: (2021)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
por: Shumar, John N., et al.
Publicado: (2021)

Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases
por: Dsouza, Kevin G., et al.
Publicado: (2023)

Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest
por: Niimura, Takahiro, et al.
Publicado: (2017)

Kamishoyosan and Shakuyakukanzoto promote recovery from paclitaxel-induced neurite retraction in PC12 cells
por: Konaka, Ken, et al.
Publicado: (2017)

Antifibrotics in India
por: Dhar, Raja
Publicado: (2019)

Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience
por: Kawamura, Kodai, et al.
Publicado: (2019)

HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic
por: Gazdhar, Amiq, et al.
Publicado: (2013)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2019)

Interstitial Pneumonia Secondary to Hermansky-Pudlak Syndrome Type 4 Treated with Different Antifibrotic Agents
por: Itano, Junko, et al.
Publicado: (2020)

In Vitro and In Vivo Antifibrotic Effects of Fraxetin on Renal Interstitial Fibrosis via the ERK Signaling Pathway
por: Hsieh, Yi-Hsien, et al.
Publicado: (2021)

Differences in the Evolution of Lung Function Before and After Treatment With Antifibrotics in Patients With Interstitial Lung Disease
por: Liendo-Martínez, Katiuska Herminia, et al.
Publicado: (2023)

Evaluation of pharmaceutical lifesaving skills training oriented pharmaceutical intervention
por: Zamami, Yoshito, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2b5cu8vcn2jnrqkj773570741e